AND this study will provide in-depth analytics related to NGS workflow

583 scientists, who currently use or plan to use Next Generation Sequencing
participated in the NGS survey between August 11 and August 31, 2011.

Rather than relying only on publicly available data, every BioInformatics LLC report is based on primary research—in this case, hundreds of scientists (not dozens as in some recent reports from other firms) using Next Generation Sequencing. The scientists answering our questions were carefully recruited based on their use of NGS instrumentation and experience with sample prep and data analysis. Our experienced analyst team is comprised of scientists AND business analysts who can interpret the scientific and business implications of the results.

In other words, no other report on the market can provide you with the confidence that you can rely on their data to make critical business decision. Whether you sell instrumentation, consumables or software for the NGS market this report provides uniquely useful data to support positioning, branding, marketing and product development in one of the fastest changing segments of the market.